A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST)
Clinical trial NCT03158103 · COMPLETED
Trial details
- NCT number
- NCT03158103
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-15
- Primary completion
- 2021-04-28
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.